Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 25, 2025
Le Parlement est en pleine campagne « poil » itique : Le vote est ouvert pour le concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
GlobeNewswire
·
April 25, 2025
OTTAWA, 25 avr. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est ravi d’annoncer que le vote du public est maintenant ouvert pour le 3e concours annuel de photos « Les animaux les plus mignons sur la Colline du Parlement »! Les …
Parliament Gets Paw-litical: Voting Open for Cutest Pets on Parliament Hill Photo Contest
GlobeNewswire
·
April 25, 2025
OTTAWA, April 25, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is thrilled to announce that public voting is now open for the 3rd Annual Cutest Pets on Parliament Hill photo contest! Canadians from coast to coast can now help choose …
Global Arterial Cannula Market to Reach USD 40 Billion by 2033, registering a CAGR of 6.6% | FMI
EIN Presswire
·
April 25, 2025
Explore key insights on the Arterial Cannula Market, including growth trends, demand drivers, and forecasts from 2023 to 2033. NEWARK, DE, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- The global arterial cannula market has witnessed remarkable …
Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"
GlobeNewswire
·
April 25, 2025
SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- In the midst of a worsening mental health crisis and rising anti-LGBTQIA+ attacks nationwide, nonprofit counseling agency Queer LifeSpace will host its largest-ever fundraiser on Friday, May 30th, rallying …
Bassett Medical Center Earns Prestigious Magnet Designation for Nursing Excellence
GlobeNewswire
·
April 25, 2025
Cooperstown, New York, April 25, 2025 (GLOBE NEWSWIRE) -- Bassett Medical Center in Cooperstown, NY, has achieved Magnet® Recognition for Nursing Excellence, the highest national honor a hospital can attain for nurse satisfaction, patient outcomes, and …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
April 25, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 25.4.2025 KLO 17.20 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
April 25, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a …
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
GlobeNewswire
·
April 25, 2025
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the Clinical …
InspireMD to Announce First Quarter 2025 Financial Results
GlobeNewswire
·
April 25, 2025
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its first quarter …
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
GlobeNewswire
·
April 25, 2025
In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), into a registrational study Company remains confident in continuing to pursue evorpacept in …
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
GlobeNewswire
·
April 25, 2025
DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“Mangoceuticals” or “MGRX”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the …
The Ebony Canal, Narrated by Viola Davis Wins Big with Two International Webby Awards for Black Infant and Maternal Health
GlobeNewswire
·
April 25, 2025
New York, New York, April 25, 2025 (GLOBE NEWSWIRE) -- Less than a week following National Black Maternal Health Week, The Ebony Canal, directed by four-time Emmy Award-winner Emmai Alaquiva and narrated by EGOT winner Viola Davis, has been honored with …
Better Choice Company Cancels Previously Announced Stock Dividend
GlobeNewswire
·
April 25, 2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it is canceling the previously declared stock dividend of 0.35 per …
Assisted Reproductive Technology Market worth US$6.02 Billion by 2030 with 7.0% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 25, 2025
Delray Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) -- The global Assisted Reproductive Technology Market, valued at US$4.02 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$4.29 billion in 2025 and an impressive US$6.02 billion …
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Awards 2025
EIN Presswire
·
April 25, 2025
Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Summit …
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
GlobeNewswire
·
April 25, 2025
TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a …
Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”
GlobeNewswire
·
April 25, 2025
DURHAM, N.C., April 25, 2025 (GLOBE NEWSWIRE) -- Codetta Bio is proud to announce the official launch of the Concerto™ System, a revolutionary new multi-omics platform, at the American Association for Cancer Research (AACR) Annual Meeting 2025. The …
VYNE Therapeutics Provides Update on VYN202 Program
GlobeNewswire
·
April 25, 2025
BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that it placed a clinical hold on the …
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
GlobeNewswire
·
April 25, 2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection with the …
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …